ATE75947T1 - Pharmazeutische zusammensetzung fuer die kombinationstherapie von hormonabhaengigem krebs. - Google Patents
Pharmazeutische zusammensetzung fuer die kombinationstherapie von hormonabhaengigem krebs.Info
- Publication number
- ATE75947T1 ATE75947T1 AT85904034T AT85904034T ATE75947T1 AT E75947 T1 ATE75947 T1 AT E75947T1 AT 85904034 T AT85904034 T AT 85904034T AT 85904034 T AT85904034 T AT 85904034T AT E75947 T1 ATE75947 T1 AT E75947T1
- Authority
- AT
- Austria
- Prior art keywords
- sex steroid
- antiandrogen
- inhibitor
- combination therapy
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/636,883 US4775660A (en) | 1984-08-02 | 1984-08-02 | Treatment of breast cancer by combination therapy |
US06/699,702 US4666885A (en) | 1985-02-08 | 1985-02-08 | Combination therapy for treatment of female breast cancer |
US06/699,711 US4659695A (en) | 1985-02-08 | 1985-02-08 | Method of treatment of prostate cancer |
US06/699,710 US5023234A (en) | 1985-02-08 | 1985-02-08 | Combination male breast cancer therapy |
EP85904034A EP0195015B1 (de) | 1984-08-02 | 1985-08-02 | Pharmazeutische zusammensetzung für die kombinationstherapie von hormonabhängigem krebs |
PCT/US1985/001454 WO1986001105A1 (en) | 1984-08-02 | 1985-08-02 | Pharmaceutical composition for combination therapy of hormone dependent cancers |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE75947T1 true ATE75947T1 (de) | 1992-05-15 |
Family
ID=27505215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT85904034T ATE75947T1 (de) | 1984-08-02 | 1985-08-02 | Pharmazeutische zusammensetzung fuer die kombinationstherapie von hormonabhaengigem krebs. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0195015B1 (de) |
JP (1) | JPH0680016B2 (de) |
AT (1) | ATE75947T1 (de) |
AU (1) | AU594309B2 (de) |
DE (2) | DE3586053D1 (de) |
DK (1) | DK168516B1 (de) |
IE (1) | IE58836B1 (de) |
WO (1) | WO1986001105A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0301850A3 (de) * | 1987-07-31 | 1990-10-31 | Syntex (U.S.A.) Inc. | LHRH-Analoge und 19-NOR-progestationäle Steroide für eine therapeutische Anwendung |
DE3733478A1 (de) * | 1987-10-01 | 1989-04-13 | Schering Ag | Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore |
HU199694B (en) * | 1988-05-10 | 1990-03-28 | Innofinance Altalanos Innovaci | Process for producing citostatic pharmaceutical compositions containing gonadoliberin derivatives |
US5686465A (en) * | 1988-10-31 | 1997-11-11 | Endorecherche Inc. | Sex steroid activity inhibitors |
US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
US5204337A (en) * | 1988-10-31 | 1993-04-20 | Endorecherche Inc. | Estrogen nucleus derivatives for use in inhibition of sex steroid activity |
EP0462189B1 (de) * | 1989-03-10 | 1995-09-27 | Endorecherche Inc. | Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen |
US5595985A (en) | 1989-03-10 | 1997-01-21 | Endorecherche Inc. | Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
US5372996A (en) * | 1989-03-10 | 1994-12-13 | Endorecherche, Inc. | Method of treatment of androgen-related diseases |
US5364847A (en) * | 1989-03-10 | 1994-11-15 | Endorecherche | Inhibitors of sex steroid biosynthesis and methods for their production and use |
DE3921059A1 (de) * | 1989-06-23 | 1991-01-10 | Schering Ag | 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel |
WO1991000733A1 (en) * | 1989-07-07 | 1991-01-24 | Endorecherche Inc. | Method of treatment of androgen-related diseases |
CA2062973C (en) * | 1989-07-07 | 2003-09-23 | Fernand Labrie | Combination therapy for prophylaxsis and/or treatment of benign prostatic hyperplasia |
US4990538A (en) * | 1989-08-23 | 1991-02-05 | Harris Adrian L | Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs |
ZA924811B (en) * | 1991-06-28 | 1993-12-29 | Endorecherche Inc | Controlled release systems and low dose androgens |
HU222501B1 (hu) * | 1991-06-28 | 2003-07-28 | Endorecherche Inc. | MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására |
US6060503A (en) * | 1991-12-02 | 2000-05-09 | Endorecherche, Inc. | Benzopyran-containing compounds and method for their use |
WO1993023053A1 (en) * | 1992-05-21 | 1993-11-25 | Endorecherche Inc. | INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY |
EP0729754A2 (de) * | 1995-02-28 | 1996-09-04 | Eli Lilly And Company | 2-Phenyl-3-Aroylbenzothiophene zur Hemmung von estrogenpositiven Tumoren des Gehirns oder ZNS |
ZA961564B (en) * | 1995-02-28 | 1997-08-27 | Lilly Co Eli | Methods of inhibiting ovarian cancer. |
MXPA00008868A (es) | 1998-03-11 | 2003-04-25 | Endorech Inc | Inhibidores de dihidrogenasa de 17 -hidroxiesteroide y metodos para su uso. |
US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
WO2003015820A1 (fr) * | 2001-08-10 | 2003-02-27 | Takeda Chemical Industries, Ltd. | Medicaments combines d'agoniste de la gnrh |
CN1551878B (zh) | 2001-09-06 | 2011-08-10 | 先灵公司 | 用于治疗雄激素依赖性疾病的3型17β-羟基类固醇脱氢酶抑制剂 |
PE20030705A1 (es) | 2001-10-17 | 2003-08-21 | Schering Corp | Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes |
JP4614770B2 (ja) | 2002-11-18 | 2011-01-19 | シェーリング コーポレイション | アンドロゲン依存性疾患を処置するための17β−ヒドロキシステロイドデヒドロゲナーゼタイプ3インヒビター |
ES2312845T3 (es) | 2002-12-17 | 2009-03-01 | Schering Corporation | Inhibidores de la deshidrogenasa de 17 beta-hidroxiesteroides de tipo 3 para el tratamiento de enfermedades dependientes de androgenos. |
GB0513702D0 (en) | 2005-07-04 | 2005-08-10 | Sterix Ltd | Compound |
GB0722779D0 (en) | 2007-11-20 | 2008-01-02 | Sterix Ltd | Compound |
CN115862804B (zh) * | 2022-11-25 | 2023-12-19 | 成都诺医德医学检验实验室有限公司 | 双药联用的联合用药的推荐方法及装置 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4329364A (en) * | 1974-09-11 | 1982-05-11 | Schering Corporation | Antiandrogenic agents and methods for the treatment of androgen dependent disease states |
FR2329276A1 (fr) * | 1975-10-29 | 1977-05-27 | Roussel Uclaf | Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant |
DE2921593C2 (de) * | 1979-05-28 | 1984-02-02 | Gränges Nyby AB, Nybybruk | Verfahren und Vorrichtung zum Weiterzerkleinern von hydriertem, grobstückigem Material, insbes. Schrott aus Titan oder dessen Legierungen |
ZA822247B (en) * | 1981-04-03 | 1983-11-30 | Lilly Co Eli | Benzothiophene compounds and process for preparing them |
-
1985
- 1985-08-02 DE DE8585904034T patent/DE3586053D1/de not_active Expired - Lifetime
- 1985-08-02 EP EP85904034A patent/EP0195015B1/de not_active Expired - Lifetime
- 1985-08-02 WO PCT/US1985/001454 patent/WO1986001105A1/en active IP Right Grant
- 1985-08-02 IE IE192985A patent/IE58836B1/en not_active IP Right Cessation
- 1985-08-02 DE DE19853590389 patent/DE3590389T1/de not_active Withdrawn
- 1985-08-02 JP JP60503509A patent/JPH0680016B2/ja not_active Expired - Lifetime
- 1985-08-02 AT AT85904034T patent/ATE75947T1/de not_active IP Right Cessation
- 1985-08-02 AU AU47282/85A patent/AU594309B2/en not_active Expired
-
1986
- 1986-04-01 DK DK147086A patent/DK168516B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK168516B1 (da) | 1994-04-11 |
IE58836B1 (en) | 1993-11-17 |
EP0195015A1 (de) | 1986-09-24 |
AU594309B2 (en) | 1990-03-08 |
DE3586053D1 (de) | 1992-06-17 |
JPS62500451A (ja) | 1987-02-26 |
DK147086D0 (da) | 1986-04-01 |
IE851929L (en) | 1986-02-02 |
DK147086A (da) | 1986-04-01 |
EP0195015B1 (de) | 1992-05-13 |
JPH0680016B2 (ja) | 1994-10-12 |
WO1986001105A1 (en) | 1986-02-27 |
DE3590389T1 (de) | 1986-08-28 |
AU4728285A (en) | 1986-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE75947T1 (de) | Pharmazeutische zusammensetzung fuer die kombinationstherapie von hormonabhaengigem krebs. | |
DK0971705T3 (da) | Lægemiddelformuleringer til hormonerstatningsterapi til lokal påföring på huden | |
PT748190E (pt) | Metodos e formulacoes para uso no tratamento de disturbios ginecologicos benignos | |
ATE128362T1 (de) | Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen. | |
TR200002751T2 (tr) | Sistemik etkisi olan lokal hormon terkibi | |
MX9606501A (es) | Composiciones antifungosas y curativas para heridas y metodos para preparar y utilizar las mismas. | |
DK0836506T4 (da) | Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen | |
ES2176190T3 (es) | Inhibidores de la actividad de esteroides sexuales. | |
RU95113862A (ru) | Производные пирролопиримидинов, фармацевтическая композиция, промежуточные соединения | |
CA2062792A1 (en) | Treatment of androgen-related diseases | |
ATE77388T1 (de) | Steroid-5-alpha-reduktase-inhibitoren. | |
DK550188A (da) | Antigestagen- og antioestrogenvirksomme forbindelser til behandling af hormonafhaengige tumorer | |
CA2034484A1 (en) | Radioimmunotherapy using .alpha.-particles emission | |
ES8307744A1 (es) | Un metodo para la preparacion de nuevos derivados de sales de metales alcalinos de acidos 2-pirrolidon-4-carboxilicos. | |
AR003176A1 (es) | Una composicion farmaceutica para inhibir el crecimiento de cancer | |
DE59911734D1 (de) | Kombination von selen-haltigen verbindungen mit gemcitabin oder mitomycin c | |
MX9504023A (es) | Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion. | |
GB2138286A (en) | Pharmaceutical composition for the treatment of hair loss | |
DK1200107T3 (da) | Præparater der har steroid östrogenvirkning, hvilke præparater ikke öger risikoen for brystcancer | |
CL2004000579A1 (es) | Uso de dienogest para preparar composiciones farmaceuticas destinadas a reducir el cuerpo de la glandula mamaria. | |
ATE82113T1 (de) | Topische zusammensetzungen. | |
Fernö et al. | 315 The binding of Tamoxifen in cytosol samples from human breast cancer | |
GB1276097A (en) | Improvements in or relating to phloroglucinol derivatives | |
ES395365A1 (es) | Procedimiento para la obtencion de agentes anticonceptivos. | |
MY107387A (en) | Aromatic steroid 5-(alpha)-reductase inhibitors. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |